[ 18 F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management

This publication has 30 references indexed in Scilit:

• Ca 15-3 in the follow-up of localised breast cancer: a prospective study
  European Journal Of Cancer, 2002
• Detection of Occult Disease in Breast Cancer Using Fluorodeoxyglucose Camera-Based Positron Emission Tomography
  Clinical Breast Cancer, 2001
• Positive Emission Tomography for Evaluating a Complete Clinical Response in Patients with Ovarian or Peritoneal Carcinoma: Correlation with Second-Look Laparotomy
  Gynecologic Oncology, 2001
• Value of Iterative Reconstruction, Attenuation Correction, and Image Fusion in the Interpretation of FDG PET Images with an Integrated Dual-Head Coincidence Camera and X-Ray-based Attenuation Maps
  Radiology, 2001
• FDG PET Evaluation of Mucinous Neoplasms
  American Journal of Roentgenology, 2000
• The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer
  Clinical Positron Imaging, 2000
• Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
  American Journal of Roentgenology, 1998
• Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.
  Radiology, 1998
• What are the benefits of routine breast cancer follow-up?
  Published by Oxford University Press (OUP) ,1992
• Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases
  Breast Cancer Research and Treatment, 1989